Document Type
Presentation
Presentation Date
9-9-2021
Abstract
Introduction
- Teratogenic medications are commonly prescribed to individuals with pregnancy potential
- Despite knowledge of potential teratogenic effects, data suggest that effective communication regarding the risks and benefits of medication use in the context of the patient’s fertility goals remains inadequate
- We will discuss recommendations for changes in education and healthcare delivery to facilitate thoughtful prescribing in this population
Learning Objectives
- To review a common scenario faced by primary care physicians caring for individuals at risk of pregnancy
- To recognize factors that might place certain patients at increased risk of teratogenic exposure in early pregnancy
- To gain competence in assessing fertility goals in the setting of medication prescribing
Outline
- Case Presentation
- Background
- Definitions & Safety Categories
- Commonly Prescribed Teratogenic Medications
- Chronic Disease in women with pregnancy potential
- "Having the conversation”
- Challenges
- Recommendations
- Summary
Recommended Citation
Foster, MD, MPH, FAAFP, Krys, "Teratogenic medication usage in primary care of women of reproductive age" (2021). Department of Family & Community Medicine Presentations and Grand Rounds. Paper 506.
https://jdc.jefferson.edu/fmlectures/506
Language
English
